AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON
By GlobeNewswire Published on May 15, 2025, 12:01 IST
VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) — AMERICAN SALARS LITHIUM INC. ('AMERICAN SALARS' OR THE 'COMPANY') (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY) announces the addition of Dr. Mark King PhD, PGeo, FGC, a world-renowned lithium brine expert, as a Technical Advisor and Qualified Person.
Dr. King is a hydrogeologist with 30+ years of international experience in groundwater modeling and geochemistry. For the past 15 years, he has specialized in exploration and evaluation of lithium brine projects. His strong chemistry and numerical modeling background has proven to be an excellent foundation for brine exploration and quantitative evaluation. Consequently, his resource and reserve estimation experience on major brine projects is now arguably the most extensive of any geologist, hydrogeologist, or engineer in the world.
Some notable past involvements include serving as a resource and/or reserve estimation Qualified Person for the following: Albermarle at Salar Atacama (Chile), Silver Peak (Nevada, USA) and Antofalla Salar (Argentina) Neo Lithium at the 3Q Salar, (Argentina) Lithium Americas at the Cauchari Salar, (Argentina) Vulcan Energy in the Rhine Valley, (Germany) Alpha Lithium at Tolillar & Hombre Muerto Salar, (Argentina)
In addition, Dr. King and his team have conducted detailed due diligence reviews of 20+ advanced brine projects and reconnaissance reviews (and ranking) of 100+ greenfield to early-stage projects, in South America and the southern US. His technical team at GWI have advanced expertise in geological modelling, GIS, data management and 3D visualization. They will provide exploration and resource consulting services to American Salars from time to time.
R. Nick Horsley, CEO & Director States, 'American Salars is yet again adding depth to its technical team. We are fortunate to welcome Dr. King and his team at GWI to American Salars and look forward to working together in our search for significant lithium salar projects. Mark is a globally recognized authority whose work has taken him to lithium brine projects throughout North and South America, and beyond.'
About American Salars Lithium Inc.
About American Salars Lithium Inc. American Salars Lithium Inc. is an exploration company focused on exploring and developing high-value battery metals projects to meet the demands of the advancing electric vehicle market.
All Stakeholders are encouraged to follow the Company on its social media profiles on LinkedIn, Twitter and Instagram.
On Behalf of the Board of Directors,
'R. Nick Horsley '
R. Nick Horsley, CEO
For further information, please contact:
American Salars Lithium Inc. Phone: 604.880.2189
E-Mail: [email protected]
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding American Salar's intention to continue to identify potential transactions and make certain corporate changes and applications. Forward looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance, or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits American Salars will obtain from them. These forward-looking statements reflect managements' current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause actual results to differ materially from those expressed or implied by the forward-looking statements, including American Salars results of exploration or review of properties that American Salars does acquire. These forward-looking statements are made as of the date of this news release and American Salars assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements, except in accordance with applicable securities laws.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ('PharmAla' or the 'Company') (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), has become aware of unknown parties illegally retailing a nasal spray online, falsely claiming to be a PharmAla Biotech product and unlawfully using PharmAla logos and trademarks. PharmAla is issuing this warning in order to protect consumers and LaNeo MDMA drug products are exclusively available through a qualified practitioner's prescription and Health Canada authorization and administered under the oversight of medical professionals. PharmAla does not, and will not, sell any products directly to consumers; PharmAla does not currently produce a nasal spray. The contents of any nasal spray purporting to be made by PharmAla are unknown and could be harmful to human health. PharmAla strongly urges any and all users who have purchased any unauthorized product to responsibly dispose of it immediately. PharmAla Biotech's mission remains unchanged: to support individuals with legitimate medical needs with the supply of clinical grade LaNeo™ MDMA through legal and regulated channels. We will continue to advance this mission through our work with clinical trials and Health Canada's Special Access Program (SAP). Qualified medical practitioners seeking access for their patients through the SAP can submit applications directly to Health Canada. Practitioners are also encouraged to register through our dedicated portal at: For more details on Health Canada's Special Access Program for psychedelic-assisted psychotherapy, visit: If you have questions about obtaining legitimate PharmAla products, the special access program, or wish to report suspicious products claiming association with our brand, please reach out to us directly for more information and assistance. About PharmAla PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) is a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules, including MDMA. PharmAla was founded with a dual focus: alleviating the global backlog of generic, clinical-grade MDMA to enable clinical trials as well as commercial sales in selected jurisdictions, and to develop novel drugs in the same class. PharmAla is the only company currently provisioning clinical-grade MDMA for patient treatments outside of clinical trials. PharmAla's research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. PharmAla is a 'regulatory first' organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with regulators. For more information, please contact:Nicholas KadyshChief Executive OfficerPharmAla Biotech Holdings press@ 1-855-444-6362Website: Neither the CSE nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as 'plans', 'strategy', 'expects' or 'does not expect', 'intends', 'continues', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or may contain statements that certain actions, events or results 'will be taken', 'will launch' or 'will be launching', 'will include', 'will allow', 'will be made' 'will continue', 'will occur' or 'will be achieved'. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding the use of proceeds from the Offering, the Company continuing to grow its revenue and the Company building on the success of this past year. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading 'Risk Factors' in the Company's management's discussion and analysis, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws. A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
40 minutes ago
- Associated Press
Rio Grande Resources Announces Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / May 30, 2025 / Rio Grande Resources Ltd. (CSE:RGR)(OTC PINK:RGRLF) ('Rio Grande' or 'RIO' the 'Company'), is pleased to announce non-brokered private placement of up to 13,328,900 units of the Company (each a 'Unit') at a price of $0.10 per Unit for gross proceeds of up to $1,332,890 (the 'Private Placement'). Each Unit will consist of one common share (each, a 'Share') and one transferrable common share purchase warrant (each, a 'Warrant'). Each Warrant entitles the holder to purchase one additional Share of the Company at a price of $0.20 per Share for a period of 30 months from the date of issuance. Directors and officers of the Company may acquire securities under the Private Placement, which will be considered a 'related party transaction' as defined under Multilateral Instrument 61-101 ('MI 61-101"). Such participation is expected to be exempt from the formal valuation and minority shareholder approval requirements of MI 61-101. The net proceeds from the Placement will be allocated towards exploration activities and for general corporate purposes. In accordance with the regulations of the Canadian Securities Exchange ('CSE'). All securities issued pursuant to the Private Placement will be subject to a hold period of four months and one day as required under applicable securities legislation. Closing of the Private Placement is expected to occur on or around June 06, 2025. The securities offered under the Private Placement have not been, nor will they be, registered under the U.S. Securities Act, as amended, or any state securities law, and may not be offered, sold or delivered, directly or indirectly, within the United States, or to or for the account or benefit of U.S. persons, absent registration or an exemption from such registration requirements. This news release does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of securities in any state in the United States in which such officer, solicitation or sale would be unlawful. About Rio Grande Resources Rio Grande Resources (CSE:RGR) is a burgeoning mineral exploration company focused on unlocking the high-grade gold and silver potential within its 3,000-acre drill-ready property in the Black Range of Sierra County, New Mexico. The company holds 100% interest in the Winston project group, which includes the 2 patented historic Ivanhoe & Emporia Claims, and Little Granite mines, all known for their past production of high-grade precious metals. Rio Grande Resources is led by a team of experienced professionals with expertise in mineral exploration and development, who are targeting large-scale precious metal discoveries within the property's well-documented low-sulfidation epithermal setting. To view the company fact sheet and corporate presentation, please visit our website at . Contact and Information Company Jason Barnard, President CEO and Director (604) 767-6598 [email protected] Investor Relations Contact Lucas A. Zimmerman & Ian Scargill MZ Group - MZ North America (262) 357-2918 [email protected] Follow us or contact us on social media X: @RioGrandeRGR LinkedIn: Facebook: Forward-Looking Statements Except for the statements of historical fact contained herein, the information presented in this news release and oral statements made from time to time by representatives of the Company are or may constitute 'forward-looking statements' as such term is used in applicable United States and Canadian laws and including, without limitation, within the meaning of the Private Securities Litigation Reform Act of 1995, for which the Company claims the protection of the safe harbor for forward-looking statements. Such forward-looking statements and forward-looking information include, but are not limited to, the Company's expectations with respect to the Private Placement; the use of proceeds under the Private Placement; completion of the Private Placement and the date of closing. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as 'expects' or 'does not expect,' 'is expected,' 'anticipates' or 'does not anticipate,' 'plans,' 'estimates' or 'intends,' or stating that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved) are not statements of historical fact and should be viewed as forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, continuity of agreements with third parties, the satisfaction of the conditions to the Private Placement, risks and uncertainties associated with the environment and delays in obtaining governmental approvals, permits or financing. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings on SEDAR+. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities. Please refer to the Company's most recent filings under its profile on SEDAR+ at for further information respecting the risks affecting the Company and its business. The CSE has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. SOURCE: Rio Grande Resources press release
Yahoo
40 minutes ago
- Yahoo
Nextleaf Reports Profitable Second Quarter FY25 Results Including Increased Revenue Growth and Positive Net Income Improvement
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science company and licensed cannabis processor, is pleased to announce its financial results for the second quarter of fiscal year 2025, ended March 31 2025. The Company reported gross revenue of $4,698,331, net revenue of $3,515,435 and gross profit of $1,348,054. The Company has continued making substantial improvements in net income at $348,789 while maintaining a gross profit margin at 29%. Q2 FY2025 Highlights Strong Revenue and Profitability: Gross revenue reached $4.70 million, reflecting a 22% increase from $3.85 million in the previous quarter. Gross profit totaled $1.35 million, up 42% from $950,516 in the same period last year, with a steady gross margin of 29%. Net income came in at $348,789, marking a strong turnaround from a net loss of $1.1 million during the same quarter in 2024. Positive EBITDA1 at $946,482 YTD, highlighting the Company's operational efficiency and disciplined cost management. Strengthened Balance Sheet: As of March 31, 2025, the Company had total assets of $9.0 million and working capital of $2.7 million, up from $1.6 million on September 30, 2024. The Company maintained a healthy current ratio of 1.85 and concluded the quarter with no secured debt, reflecting strong near-term financial stability. Shareholders' equity rose to $5.5 million, reflecting improved profitability and a reduction in deficit. Commercial Expansion: Product Launches: 8 new product launches under house-brand Glacial Gold across 3 categories including: 2 infused pre-rolls, 4 vapes, and 2 bottled oils, emphasizing the Company's continued focus on high potency and high purity extracts, infused products, ready-to-consume, and convenience-based formats. "From compliance to commercialization, we are proving that constraints-based innovation can happen across all areas of the business. We are setting the standard for capacity utilization, fiscal discipline, and resourcefulness. Since Day 1 our team has turned challenges into opportunities for improved efficiency, output and strategic progress." Shares Emma Andrews, Nextleaf CEO. Q3 FY2025 Outlook The Company will prioritize and allocate working capital to the following strategic initiatives throughout the third quarter of FY2025: Facility expansion and optimization allowing for continued investment into inventory to fulfill domestic demand in recreational and medical channels. Adding operational bench strength through key hires to support ERP integration, Quality Assurance, and Manufacturing. Research and development for category expansion, and new product formats. Market expansion into Quebec in partnership with Quebec Craft Cannabis. Trade marketing for strategic retail partnerships with an emphasis on education and a national sampling program. Relaunching (Summer 2025) for improved brand awareness, conversion and customer engagement. About Nextleaf Solutions Ltd. Nextleaf® is an innovation-driven life science company, and licensed cannabis processor with a portfolio of federally regulated emerging consumer brands, market validated cannabis derivative products, and high-potency bulk ingredients. Nextleaf's multi-patented, highly automated, closed loop extraction and distillation technology sets the global standard for processing cannabis at scale. With coast-to-coast distribution, Nextleaf branded products and ingredients are sold through both medical and recreational channels. Featuring the acclaimed brand Glacial Gold, leading multiple categories nationally, including cannabis softgels, vapes, and oils. The Company has been issued 19 U.S. patents, and 75+ patents globally, on cannabinoid processing including extraction, distillation, and acetylation. On behalf of the Board of Directors of the Company, Emma Andrews, CEO Contact: investors@ Nextleaf Solutions on LinkedInLearn More: Nextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange. Disclaimers and Disclosure Statements: Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release. Non-IFRS Financial Measures This press release includes references to "EBITDA", which are not defined under International Financial Reporting Standards (IFRS). The intent of these non-IFRS measures is to provide additional useful information to investors and analysts. These non-IFRS measures do not have a standardized meaning prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other entities. As such, these non-IFRS measures should not be considered in isolation or used as a substitute for measures of performance prepared in accordance with IFRS. EBITDA is considered as a useful measure by management to understand the profitability of Nextleaf Solutions excluding the effects of certain non-operating items. 1 Non-IFRS or supplementary financial measure. See discussion in the Non-IFRS Financial Measures advisories section of this press release below and Management Discussion & Analysis. To view the source version of this press release, please visit
